Commercialization: Page 70
-
PharmaVoice Team/PharmaVoice
Comparative Effectiveness Research — Watch and Worry or Weigh In and Leverage?
A little-publicized provision of the American Recovery and Reinvestment Act of 2009 is likely to have at least as big, if not a bigger, long-term impact on the pharmaceutical and medical device business as the recently passed Affordable Care Act. This provision allocated $1.1 billion for comparat...
By Dr. Ramana Yalamanchili • Aug. 27, 2010 -
PharmaVoice Team/PharmaVoice
View on Med Ed: Refining the Formula
Amid public protests from high-profile figures such as former AHA President Clyde Yancy, M.D., and National Institutes of Health Director Francis Collins, M.D., Ph.D., in June the Accreditation Council for Continuing Medical Education (ACCME) provided additional guidance to its 2004 Standards for...
By Carolyn Gretton • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
Nichebusters vs.Blockbusters
Transformation in the industry is everywhere, driven by healthcare reform, increased regulatory scrutiny, patent expiry cliffs, and thinning pipelines. The old ways of doing anything — drug development, drug research, sales, marketing, launch activities, market research — are no longer effective ...
By Robin Robinson • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
Midlevel Healthcare Providers: An Untapped Prescribing Force
Billions of prescriptions — and millions of dollars — are being influenced by a group of individuals who go largely untapped when it comes to communications, outreach, and education. Nurse practitioners (NPs) and physician assistants (PAs) wrote 7.8% of U.S. prescriptions — 308 million from June ...
By Denise Myshko • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Lonnel COATS Eisai Names CEO for U.S. Subsidiary Eisai Inc., a U.S. subsidiary of Japan’s Eisai Co., has promoted Lonnel Coats to president and CEO, from president and chief operating officer. In addition, Mr. Coats has been appointed senior VP of Eisai Co.’s pharmaceuticals b...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Pharma Could Benefit from Earlier Planning of Counter-Generics Strategies Sidebars: Counter-Generics Strategies Used by All Companies in Past 3 Years (2008-2010) Changes in Medical Treatment in Past Year Due to Economic ...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
What's New
Barnett Educational Services has announced the release of updated editions of three of its market intelligence and clinical practices guides. PAREXEL’S BIOPHARMACEUTICAL R&D STATISTICAL SOURCEBOOK 2010/2011 includes statistics, trends, and proprietary market intelligence and analysis on the b...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
The Reading List
FICTION The White Tiger: A Novel • Aravind Adiga The Pregnant Widow • Martin Amis New York Trilogy • Paul Auster The Wettest County in the World: A Novel Based on a True Story • Matt Bondurant The Lost Symbol • Dan Brown Death Comes for the Archbishop • Willa Cather and A.S. Byatt Await Your Repl...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
Lighter Moments
Michael Agard • Sanofi-Aventis US I was traveling for business in Paris with some colleagues. I had arranged a wake-up call with the hotel. My colleagues called about 1 a.m. to tell me about plans for the following day. Instead of listening to their phone call, I thought it was the wake-up call a...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The MENTORS
The MENTORS People’s People We salute those who take the time out of their own busy careers to help others to develop their paths to success; provide guidance; and exhibit patience, foresight, and unselfish devotion to mentoring. Knowledge is most valuable when shared, and Wendy Blackburn is one ...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The TECHNOLOGISTS
Not many people have created two health-related companies, nor have had them both successfully acquired before their 30th birthday. But Hugo Stephenson, M.D., has an ability to see what others cannot and the energy to make things happens. As he says, he’s never yet met a challenge that could not ...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The CLINICAL SPECIALISTS
Patients have a powerful advocate in Craig Lipset. A recognized speaker and author on innovation in clinical trials and improving patient engagement in research, Mr. Lipset has recently been leading industry efforts around personalized medicine. An entrepreneurial and innovative individual, Mr. L...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The CHANGE AGENTS
It was apparent from the start of his career that Leo Francis, Ph.D., was a leader in the making. From his early days in the industry, Dr. Francis’ professionalism and inexorable drive for excellence in all aspects of his work have shone through. His achievements have led to extraordinary progre...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
On The Calendar
July 15-16 Effective Document Management for the Pharmaceutical, Biotech & Medical Device Industries The Hilton Hotel, Orange County/ Costa Mesa, Calif. The Center for Professional Innovation and Education, http://www.cfpie.com/showitem.aspx?productid=027&source=pv July 15-16 Managed Care...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: FDA, NIH Launch Electronic Safety Reporting Portal Insurance Documentation System Helps Prevent Study Delays GSW Worldwide Unveils New Website and Blog Derycz Scientific Offers Solution for Electronic Article Reus...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Financial Disclosure Compliance is Still an Issue for Life-Sciences Firms Sidebars: Slow Outsourcing of Disclosure Reporting Sources for Adverse Event Reports Online Collection of Adverse Event Reports Lags Traditional M...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
Who's on the List by Company
Anavex Life Sciences Cameron Durrant, M.D. 18 ApotheCom David Dunn 16 Astellas Pharma US Margaret Long 73 AstraZeneca David Brennan 46 bioCapture Johanna Allston, Ph.D. 12 C3i Robert Piwko 112 Cegedim Dendrite Angela Miccoli 74 Cipla Ltd. Yusuf Hamied, Ph.D. 19 ClearTrial Mike Soenen 29 closerloo...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The PharmaVOICE 100: 2010 Every year, I think this is it, we’ve reached the pinnacle. And yet, every year, I continue to be amazed by the individuals whom our readers have identified as the most inspiring, motivating, and outstanding leaders in the life-sciences industry. This special issue, n...
By Taren Grom • July 28, 2010 -
PharmaVoice Team/PharmaVoice
2010 DIA Preview
PharmaVOICE is pleased to once again publish this Special Feature showcasing the new products, services, tools, and executive appointments and promotions at clinical-services companies that will be exhibiting at the DIA 46th Annual Meeting, June 13-17, 2010, in Washington, D.C. For your convenie...
By PharmaVoice Team • May 24, 2010 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Dr. Roger POMERANTZ Merck Appoints Head of Infectious Diseases Merck has named Roger Pomerantz, M.D., senior VP of Merck Research Laboratories (MRL) and infectious diseases franchise head. Dr. Pomerantz spent the last five years at Johnson & Johnson, where he most recently...
By PharmaVoice Team • May 24, 2010 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: AAPS Relaunches Online Career Center QuestaWeb Adds to Global Trade Management Suite SAS Releases Social Media Enterprise Solution Web Site Provides PwC Health Reform Insights Sidebar: E-upgrades and enhancements...
By PharmaVoice Team • May 24, 2010 -
PharmaVoice Team/PharmaVoice
What's New
SciQuest has launched the Procurement Business Assessment, a service that enables life-sciences companies to uncover cost-saving opportunities in their procurement operations. Procurement professionals often lack the resources and time to conduct the deep analysis of purchasing processes, systems...
By PharmaVoice Team • May 24, 2010 -
PharmaVoice Team/PharmaVoice
PharmaTrax
n The value of the global market for therapeutic vaccines is estimated at $137 million in 2010, but the market entry of new vaccines to treat cancer and nicotine addiction is expected to propel the category to almost $3.1 billion in 2014, for a four-year compound annual growth rate (CAGR) of 117....
By PharmaVoice Team • May 24, 2010 -
PharmaVoice Team/PharmaVoice
UpFront
Awards CURE Awards Bioscience Achievements Pfizer was awarded the CURE (Connecticut United for Research Excellence) Award for Excellence for its investment in multiple approaches to treating Alzheimer’s disease. Pfizer has seven Alzheimer’s clinical projects ongoing and several more programs i...
By PharmaVoice Team • May 24, 2010 -
PharmaVoice Team/PharmaVoice
Evolution in Action
As technology and medicine have advanced over the last two decades, the strategies adopted by pharmaceutical sales and commercial models have fallen out of synch. Companies regressed from customer-focused, consultative models to a more quantitative reach and frequency approach, with a strong reli...
By Carolina Castano • April 28, 2010
Previous
